Avalon Medicines Private Limited

Avalon Medicines Private Limited - pharma in Sonipat, Haryana, India. Directors, charges & compliance details.
CIN U24239HR2022PTC107489 Incorporated 01 November 2022 ROC Haryana HQ Sonipat, Haryana, India
Active Private Limited Company pharma MSME
Revenue · FY 2025
₹14.62 Cr
▲ 157% YoY
Net loss · FY 2025
₹1.71 Cr
Net margin -11.7%
EBITDA · FY 2025
-₹24 Lakh
EBITDA margin -1.6%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹4 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings

About Avalon Medicines Private Limited

Data last updated:

Avalon Medicines Private Limited is a private limited company based in Sonipat, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 November 2022.

The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24239HR2022PTC107489.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2 Cr. It is led by directors Nitin Chhikara and Sanjeet Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 119 Sector 15, Sonipat, Haryana, India – 131001.

As per the financials filed for FY 2025, the company reported a revenue of ₹14.62 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.71 Cr (net margin -11.7%) and EBITDA of -₹24 Lakh (EBITDA margin -1.6%).

As per MCA filings, the company has open charges of ₹4 Cr on record.

Avalon Medicines Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-HR-18-0023878). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239HR2022PTC107489
Registration Number 107489
Incorporation Date 01 November 2022
ROC Haryana
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-HR-18-0023878

Recognitions & Rankings of Avalon Medicines

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-HR-18-0023878

Contact details

Avalon Medicines Private Limited's registered office is in Sonipat, Haryana.

  • Registered Address
    119 Sector 15, Sonipat, Haryana, India – 131001
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Avalon Medicines Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Avalon Medicines is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Avalon Medicines Private Limited, buy the company report.

Financials of Avalon Medicines Private Limited

FY 2025 filings available

Avalon Medicines Private Limited reported revenue of ₹14.62 Cr (up 157% YoY) for FY 2025.

Revenue · FY 2025
₹14.62 Cr ▲ 157%
Net loss · FY 2025
₹1.71 Cr margin -11.7%
EBITDA · FY 2025
-₹24 Lakh margin -1.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 157%
EBITDA CAGR growth
1 year
▼ 267%

Revenue rose 157% in the latest year. EBITDA fell 267% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹24 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.71 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin-1.6%
Net Profit Margin-11.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Avalon Medicines Private Limited, buy the company report.

Board of directors of Avalon Medicines Private Limited

Avalon Medicines has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nitin ChhikaraDirector13 May 20242 Years 6 MonthsCurrent
Sanjeet KumarDirector13 Sep 20242 Years 2 MonthsCurrent

Peer comparison

Avalon Medicines Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Fair Ford Pharmaceuticals Private Limited₹15.5 Cr (FY 2025)112.0%Faridabad, Haryana, India
Gomti Research and Pharmachem Private Limited₹15.27 Cr (FY 2024)16.0%Bangalore, Karnataka, India
Fine Processors Private Limited₹15.24 Cr (FY 2025)62.0%New Delhi, Delhi, India
Jahnavi Chem Products Private Limited₹14.93 Cr (FY 2025)42.0%Vijayawada, Andhra Pradesh, India
Emma Trading House India Private Limited₹14.63 Cr (FY 2025)Thrissur, Kerala, India
Avalon Medicines Private Limitedthis company₹14.62 Cr (FY 2025)-₹1.71 Cr-11.7%157.0%Sonipat, Haryana, India
J P Laboratories Private Limited₹14.54 Cr (FY 2025)-1.0%Pune, Maharashtra, India
Iza Pharmaceuticals Private Limited₹14.44 Cr (FY 2025)21.0%Kozhikode, Kerala, India
Keewel Healthcare Private Limited₹14.04 Cr (FY 2025)18.0%Thane, Maharashtra, India
Sri SPR Biologics Private Limited₹13.53 Cr (FY 2024)-21.0%Macherla, Andhra Pradesh, India
Alok Pharmaceutical and Industrial Co Pvt Ltd₹13.41 Cr (FY 2025)-1.0%Delhi, India

To see the full peer comparison of Avalon Medicines Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹4.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
10 Mar 2023100691191Others₹4 CrOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Avalon Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Avalon Medicines Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Avalon Medicines Private Limited has 5 board changes on record since 2024: 2 appointments and 3 cessations. The latest: Aayush Gupta ceased to be Director on 18 Sep 2024.

AGM
Avalon Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Avalon Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Ceased
Aayush Gupta ceased to be Director.
Appointed
Sanjeet Kumar was appointed as Director.
Ceased
Nitin Chhikara ceased to be Additional Director.
Ceased
Surender Kumar ceased to be Director.
Appointed
Nitin Chhikara was appointed as Director.
Charges
A charge with Others amounted to Rs. 4.00 Cr with Charge ID 100691191 was registered on 10 Mar 2023.
Incorporation
01 Nov 2022
Avalon Medicines Private Limited was registered on 01 Nov 2022 with Roc Haryana & aged 4 years 15 days as per MCA records.

Frequently asked questions

Avalon Medicines is an active private limited company based in Sonipat, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 November 2022 (4+ years old) and is registered under CIN U24239HR2022PTC107489.

Avalon Medicines has 2 current directors:

The latest financial statements of Avalon Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Avalon Medicines is U24239HR2022PTC107489. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Avalon Medicines was incorporated on 01 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Haryana.

The peers of Avalon Medicines by revenue are Fair Ford Pharmaceuticals Private Limited, Gomti Research and Pharmachem Private Limited, Fine Processors Private Limited, Jahnavi Chem Products Private Limited, Emma Trading House India Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).

Aayush Gupta ceased to be Director on 18 Sep 2024. Sanjeet Kumar was appointed as Director on 13 Sep 2024. Nitin Chhikara ceased to be Additional Director on 12 Sep 2024. Avalon Medicines has 5 board changes on record in total.

Yes, Avalon Medicines is registered as an MSME under Udyam registration (number: UDYAM-HR-18-0023878).

The registered office of Avalon Medicines is at 119 Sector 15, Sonipat, Haryana, India – 131001.

Avalon Medicines operates in the pharma industry, in the drug formulation and development segment.

Avalon Medicines has open charges of ₹4 Cr and no satisfied charges on record as per latest MCA filings.